Fate Therapeutics Inc (FATE)
2.605
-0.16
(-5.62%)
USD |
NASDAQ |
Nov 05, 12:05
Fate Therapeutics Price: 2.605 for Nov. 5, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 04, 2024 | 2.40 | 2.79 | 2.31 | 2.76 | 2.074M |
Nov 01, 2024 | 2.42 | 2.481 | 2.32 | 2.43 | 1.812M |
Oct 31, 2024 | 2.49 | 2.50 | 2.27 | 2.37 | 1.829M |
Oct 30, 2024 | 2.70 | 2.71 | 2.47 | 2.49 | 1.239M |
Oct 29, 2024 | 2.87 | 2.88 | 2.665 | 2.72 | 1.126M |
Oct 28, 2024 | 2.70 | 2.87 | 2.67 | 2.87 | 2.213M |
Oct 25, 2024 | 2.81 | 2.81 | 2.64 | 2.65 | 2.066M |
Oct 24, 2024 | 3.03 | 3.04 | 2.80 | 2.81 | 1.019M |
Oct 23, 2024 | 3.17 | 3.21 | 3.00 | 3.03 | 1.053M |
Oct 22, 2024 | 3.14 | 3.24 | 3.08 | 3.19 | 609634.0 |
Oct 21, 2024 | 3.21 | 3.25 | 3.075 | 3.15 | 1.846M |
Oct 18, 2024 | 3.23 | 3.32 | 3.185 | 3.23 | 741041.0 |
Oct 17, 2024 | 3.19 | 3.265 | 3.110 | 3.22 | 753337.0 |
Oct 16, 2024 | 3.07 | 3.249 | 2.985 | 3.21 | 1.330M |
Oct 15, 2024 | 3.05 | 3.125 | 2.945 | 3.05 | 728180.0 |
Oct 14, 2024 | 3.06 | 3.10 | 3.02 | 3.05 | 776331.0 |
Oct 11, 2024 | 2.96 | 3.10 | 2.925 | 3.09 | 1.042M |
Oct 10, 2024 | 2.96 | 2.970 | 2.85 | 2.94 | 1.039M |
Oct 09, 2024 | 3.07 | 3.14 | 2.96 | 3.01 | 1.035M |
Oct 08, 2024 | 3.04 | 3.15 | 2.98 | 3.07 | 1.720M |
Oct 07, 2024 | 3.18 | 3.265 | 2.91 | 3.05 | 2.456M |
Oct 04, 2024 | 3.23 | 3.35 | 3.16 | 3.22 | 935051.0 |
Oct 03, 2024 | 3.17 | 3.23 | 3.06 | 3.12 | 1.163M |
Oct 02, 2024 | 3.28 | 3.315 | 3.15 | 3.21 | 1.116M |
Oct 01, 2024 | 3.47 | 3.47 | 3.28 | 3.35 | 856957.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.65
Minimum
Oct 27 2023
117.40
Maximum
Jan 14 2021
31.03
Average
24.18
Median
Apr 07 2020
Price Benchmarks
NovaBay Pharmaceuticals Inc | 0.77 |
Palatin Technologies Inc | 1.17 |
iBio Inc | 2.67 |
Theriva Biologics Inc | 2.03 |
Oragenics Inc | 0.3149 |
Price Related Metrics
PS Ratio | 21.98 |
Price to Book Value | 0.7472 |
Earnings Yield | -65.64% |
Market Cap | 296.65M |